Kai-Jiang Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kai-Jiang Yu has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Rui-Tao Wang
Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China
9 shared publications Tiemin Liu
Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, 150081, China
9 shared publicationsZhi-Ping Liu
Departments of Internal Medicine and Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA
6 shared publicationsXin Zhang
Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, 150081, China
4 shared publicationsZhi-Yuan Yun
Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150081, China
4 shared publicationsMing-Ming Cui
Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150081, China
3 shared publications
Latest Publications
- Open Access
- 10 June 2020
- Published by Springer Nature in Research Square
Lymphopenia Predicts Early Mortality in Cancer Patients with Sepsis, A Retrospective Study of Medical Records
Background: Postoperative sepsis in cancer patients becomes a major problem at present, but the efficiently prognostic biomarkers are limited. The present study was sought to evaluate the prognostic relevance of absolute lymphocyte counts (ALCs) in cancer patients with postoperative sepsis, which might help patients to get early treatment and improve their prognosis.Methods: Retrospective study was conducted under 368 cancer patients with postoperative sepsis who were admitted in ICU of two Chinese tertiary care hospitals from January 1, 2016 to December 31, 2017. ALCs were daily collected during the first week after being enrolled in the study. The primary outcomes of the study included 28-day and 90-day mortalities, while the secondary outcomes were hospital and ICU length of stay.Results: The absolute lymphocyte counts on day 3 were reduced in the survivors comparing with those in non-survivors. Statistically, the significantly decreased 28-day and 90-day survival rates were detected in the patients with severe and moderate lymphopenia, compared to those with no lymphopenia. These present results were consistently found and evidently confirmed in the two different hospitals.Conclusions: In accordance with the day-4 lymphopenia prediction of sepsis diagnosis, this present study revealed that lymphopenia on the day 3 after the diagnosis of sepsis was able to predict the early mortality in postoperative cancer patients. Earlier monitoring and management of lymphopenia may be needed for cancer patients with postoperative sepsis.
- 10 June 2020
- Published by Springer Nature in Research Square
Open AccessLymphopenia Predicts Early Mortality in Cancer Patients with Sepsis, A Retrospective Study of Medical Records
Background: Postoperative sepsis in cancer patients becomes a major problem at present, but the efficiently prognostic biomarkers are limited. The present study was sought to evaluate the prognostic relevance of absolute lymphocyte counts (ALCs) in cancer patients with postoperative sepsis, which might help patients to get early treatment and improve their prognosis.Methods: Retrospective study was conducted under 368 cancer patients with postoperative sepsis who were admitted in ICU of two Chinese tertiary care hospitals from January 1, 2016 to December 31, 2017. ALCs were daily collected during the first week after being enrolled in the study. The primary outcomes of the study included 28-day and 90-day mortalities, while the secondary outcomes were hospital and ICU length of stay.Results: The absolute lymphocyte counts on day 3 were reduced in the survivors comparing with those in non-survivors. Statistically, the significantly decreased 28-day and 90-day survival rates were detected in the patients with severe and moderate lymphopenia, compared to those with no lymphopenia. These present results were consistently found and evidently confirmed in the two different hospitals.Conclusions: In accordance with the day-4 lymphopenia prediction of sepsis diagnosis, this present study revealed that lymphopenia on the day 3 after the diagnosis of sepsis was able to predict the early mortality in postoperative cancer patients. Earlier monitoring and management of lymphopenia may be needed for cancer patients with postoperative sepsis.
- 18 April 2019
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 24 (4) , 515-519
Platelet indices in non-small cell lung cancer patients with brain metastases
BACKGROUND: Platelets play a crucial role in cancer progression and metastasis. The aim of the present study was to assess the relationship between platelet indices and non-small cell lung cancer (NSCLC) with brain metastases. METHODS: Between Januar
- 18 April 2019
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 24 (4) , 515-519
Platelet indices in non-small cell lung cancer patients with brain metastases
BACKGROUND: Platelets play a crucial role in cancer progression and metastasis. The aim of the present study was to assess the relationship between platelet indices and non-small cell lung cancer (NSCLC) with brain metastases. METHODS: Between Januar
- Open Access
- 31 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-6
Elevated mean platelet volume predicts poor prognosis in colorectal cancer
Altered mean platelet volume (MPV) is implicated in several malignancies. However, the clinicopathological significance and prognostic value of MPV in colorectal cancer (CRC) is still elusive. The purpose of this study was to elucidate the predictive significance of MPV in CRC. The retrospective study recruited 509 consecutive CRC patients between January 2009 and December 2009. The relationships between MPV and clinicopathological characteristics were analyzed. Kaplan-Meier method and Cox regression were used to evaluate the prognostic impact of MPV. Of the 509 CRC patients, high MPV levels were detected in 150 (29.5%) patients. Elevated MPV was associated with tumor differentiation (p < 0.001). Patients with increased MPV had poor overall survival compared with those with normal level (60.0% vs. 83.6%, log-rank test, p = 0.035). Cox regression analysis showed that MPV was an independent prognostic factor in CRC (HR = 1.452, 95% CI = 1.118–1.884, p = 0.005). In conclusion, MPV is easily available in routine blood test. Elevated MPV might act as a marker of prognosis and therapeutic target for CRC.
- 31 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-6
Open AccessElevated mean platelet volume predicts poor prognosis in colorectal cancer
Altered mean platelet volume (MPV) is implicated in several malignancies. However, the clinicopathological significance and prognostic value of MPV in colorectal cancer (CRC) is still elusive. The purpose of this study was to elucidate the predictive significance of MPV in CRC. The retrospective study recruited 509 consecutive CRC patients between January 2009 and December 2009. The relationships between MPV and clinicopathological characteristics were analyzed. Kaplan-Meier method and Cox regression were used to evaluate the prognostic impact of MPV. Of the 509 CRC patients, high MPV levels were detected in 150 (29.5%) patients. Elevated MPV was associated with tumor differentiation (p < 0.001). Patients with increased MPV had poor overall survival compared with those with normal level (60.0% vs. 83.6%, log-rank test, p = 0.035). Cox regression analysis showed that MPV was an independent prognostic factor in CRC (HR = 1.452, 95% CI = 1.118–1.884, p = 0.005). In conclusion, MPV is easily available in routine blood test. Elevated MPV might act as a marker of prognosis and therapeutic target for CRC.
- Open Access
- 27 July 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 6700
Lower mean platelet volume predicts poor prognosis in renal cell carcinoma
Altered mean platelet volume (MPV) is found in several malignancies. Remarkably, there is little consensus on using the value of MPV in the prognostic evaluations of renal cell carcinoma (RCC). The aim of this study is to examine the feasibility of MPV value as a prognostic indicator of RCC. The retrospective study recruited 306 consecutive RCC patients between January 2009 and December 2009. The relationships between MPV and clinicopathological characteristics were analyzed. Kaplan-Meier method and Cox regression were used to evaluate the prognostic impact of MPV. Of the 306 RCC patients, low MPV levels were detected in 61 (19.9%) patients. Reduced MPV was associated with histology types, T classification, UCLA Integrated Scoring System (UISS) category, and Mayo clinic stage, size, grade, and necrosis score (SSIGN) category (P < 0.05). Patients with decreased MPV had significantly shorter survival time than patients with normal MPV (P < 0.001). Cox regression analysis revealed that reduced MPV was an independent prognostic factor for overall survival (hazard ratio, 1.758; 95% confidence interval [CI], 1.083–2.855, P = 0.023). Moreover, the prognostic accuracy of TNM stage, UISS, and SSIGN prognostic models were improved when MPV was added. In conclusion, reduced MPV is identified as an independent predictor of adverse clinical outcome in RCC.
- 27 July 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 6700
Open AccessLower mean platelet volume predicts poor prognosis in renal cell carcinoma
Altered mean platelet volume (MPV) is found in several malignancies. Remarkably, there is little consensus on using the value of MPV in the prognostic evaluations of renal cell carcinoma (RCC). The aim of this study is to examine the feasibility of MPV value as a prognostic indicator of RCC. The retrospective study recruited 306 consecutive RCC patients between January 2009 and December 2009. The relationships between MPV and clinicopathological characteristics were analyzed. Kaplan-Meier method and Cox regression were used to evaluate the prognostic impact of MPV. Of the 306 RCC patients, low MPV levels were detected in 61 (19.9%) patients. Reduced MPV was associated with histology types, T classification, UCLA Integrated Scoring System (UISS) category, and Mayo clinic stage, size, grade, and necrosis score (SSIGN) category (P < 0.05). Patients with decreased MPV had significantly shorter survival time than patients with normal MPV (P < 0.001). Cox regression analysis revealed that reduced MPV was an independent prognostic factor for overall survival (hazard ratio, 1.758; 95% confidence interval [CI], 1.083–2.855, P = 0.023). Moreover, the prognostic accuracy of TNM stage, UISS, and SSIGN prognostic models were improved when MPV was added. In conclusion, reduced MPV is identified as an independent predictor of adverse clinical outcome in RCC.
- Open Access
- 12 July 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (40) , 68115-68122
Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer
Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer
- 12 July 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (40) , 68115-68122
Open AccessDecreased mean platelet volume predicts poor prognosis in invasive bladder cancer
Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer
- Open Access
- 29 June 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (40) , 67829-67836
Cancer antigen 15-3, platelet distribution width, and fibrinogen in combination to distinguish breast cancer from benign breast disease in non-conclusive mammography patients
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Shuang Fu1, *, Zhi-Yuan Yun1, *, Ming-Ming Cui1, Hongxue Meng2, Cheng Qian3, Tiemin Liu1, 4, Zhi-Ping Liu5, Rui-Tao Wang1 and Kai-Jiang Yu6 1Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin 150081, China 2Department of Pathology, Harbin Medical University Cancer Hospital, Harbin 150081, China 3Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China 4Division of Hypothalamic Research, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA 5Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA 6Department of Intensive Care Unit, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin 150081, China *These authors have contributed equally to this work Correspondence to: Rui-Tao Wang, email: ruitaowang@126.com Kai-Jiang Yu, email: kaijiang_yu@yeah.net Keywords: breast cancer, carcinoembryonic antigen, cancer antigen 15-3, platelet distribution width, fibrinogen Received: December 20, 2016 Accepted: June 02, 2017 Published: June 29, 2017 ABSTRACT Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among females. However, mammographic diagnosis is sometimes non-conclusive with a Breast imaging Reporting and Data System (Bi-RaDS) result of 0. Cancer antigen 15-3 (CA15-3) is the most widely used serum tumor marker for breast cancer screening. Platelet distribution width (PDW) is an early indicator of platelet activation. Fibrinogen contributed to angiogenesis and distant metastasis. The aim of this study was to investigate the ability of CA15-3, PDW, and fibrinogen individually or in combination, to distinguish breast cancer from benign breast disease. 200 consecutive patients with breast cancer and 187 patients with benign breast disease were included in this retrospective study. Patients’ characteristics and hematologic tests data at initial diagnosis were collected. The benefit of adding PDW and fibrinogen to a model with only CA15-3 was evaluated as an increased in the area under the curve (AUC) obtained by receiver operating curve (ROC). CA15-3, PDW and fibrinogen are higher in breast cancer patients than in patients with benign breast disease. Single biomarkers had AUC values ranging from 0.687 for fibrinogen to 0.810 for CA15-3. In addition, the combination of PDW, CA15-3, and fibrinogen increased the AUC to 0.900 (0.866-0.928) (p<0.0001), significantly higher than those of any single marker. In conclusion, the combined use of CA15-3, PDW and fibrinogen may be clinically useful in discriminating between breast cancer and benign breast disease in non-conclusive mammography patients.
- 29 June 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (40) , 67829-67836
Open AccessCancer antigen 15-3, platelet distribution width, and fibrinogen in combination to distinguish breast cancer from benign breast disease in non-conclusive mammography patients
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Shuang Fu1, *, Zhi-Yuan Yun1, *, Ming-Ming Cui1, Hongxue Meng2, Cheng Qian3, Tiemin Liu1, 4, Zhi-Ping Liu5, Rui-Tao Wang1 and Kai-Jiang Yu6 1Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin 150081, China 2Department of Pathology, Harbin Medical University Cancer Hospital, Harbin 150081, China 3Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China 4Division of Hypothalamic Research, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA 5Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA 6Department of Intensive Care Unit, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin 150081, China *These authors have contributed equally to this work Correspondence to: Rui-Tao Wang, email: ruitaowang@126.com Kai-Jiang Yu, email: kaijiang_yu@yeah.net Keywords: breast cancer, carcinoembryonic antigen, cancer antigen 15-3, platelet distribution width, fibrinogen Received: December 20, 2016 Accepted: June 02, 2017 Published: June 29, 2017 ABSTRACT Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among females. However, mammographic diagnosis is sometimes non-conclusive with a Breast imaging Reporting and Data System (Bi-RaDS) result of 0. Cancer antigen 15-3 (CA15-3) is the most widely used serum tumor marker for breast cancer screening. Platelet distribution width (PDW) is an early indicator of platelet activation. Fibrinogen contributed to angiogenesis and distant metastasis. The aim of this study was to investigate the ability of CA15-3, PDW, and fibrinogen individually or in combination, to distinguish breast cancer from benign breast disease. 200 consecutive patients with breast cancer and 187 patients with benign breast disease were included in this retrospective study. Patients’ characteristics and hematologic tests data at initial diagnosis were collected. The benefit of adding PDW and fibrinogen to a model with only CA15-3 was evaluated as an increased in the area under the curve (AUC) obtained by receiver operating curve (ROC). CA15-3, PDW and fibrinogen are higher in breast cancer patients than in patients with benign breast disease. Single biomarkers had AUC values ranging from 0.687 for fibrinogen to 0.810 for CA15-3. In addition, the combination of PDW, CA15-3, and fibrinogen increased the AUC to 0.900 (0.866-0.928) (p<0.0001), significantly higher than those of any single marker. In conclusion, the combined use of CA15-3, PDW and fibrinogen may be clinically useful in discriminating between breast cancer and benign breast disease in non-conclusive mammography patients.
- Open Access
- 7 June 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-6
Increased platelet distribution width predicts poor prognosis in melanoma patients
Activated platelets promote cancer progression and metastasis. Nevertheless, the prognostic value of platelet indices in melanoma had been rarely reported. The aim of this study was to investigate the predictive significance of platelet indices in melanoma. A total of 220 consecutive patients with melanoma were retrospectively enrolled between January 2009 and December 2009. The relationship between PDW and clinicopathological characteristics were analyzed. Kaplan-Meier method and Cox regression were used to evaluate the prognostic impact of PDW. Of the 220 patients, high platelet distribution width (PDW) levels were observed in 63 (28.6%) patients. Increased PDW was associated with tumor subtype (P < 0.001). Survival curves found that patients with increased PDW had significantly shorter survival time than those with normal PDW (P < 0.001). Cox regression analysis revealed that elevated PDW was an independent prognostic factor for overall survival (hazard ratio, 2.480; 95% confidence interval [CI], 1.386–4.436, P = 0.002). In conclusion, PDW is easily available in routine blood test. Our findings indicated that PDW is an independent predictor and that it may also be a potential parameter for targeted therapy in melanoma.
- 7 June 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-6
Open AccessIncreased platelet distribution width predicts poor prognosis in melanoma patients
Activated platelets promote cancer progression and metastasis. Nevertheless, the prognostic value of platelet indices in melanoma had been rarely reported. The aim of this study was to investigate the predictive significance of platelet indices in melanoma. A total of 220 consecutive patients with melanoma were retrospectively enrolled between January 2009 and December 2009. The relationship between PDW and clinicopathological characteristics were analyzed. Kaplan-Meier method and Cox regression were used to evaluate the prognostic impact of PDW. Of the 220 patients, high platelet distribution width (PDW) levels were observed in 63 (28.6%) patients. Increased PDW was associated with tumor subtype (P < 0.001). Survival curves found that patients with increased PDW had significantly shorter survival time than those with normal PDW (P < 0.001). Cox regression analysis revealed that elevated PDW was an independent prognostic factor for overall survival (hazard ratio, 2.480; 95% confidence interval [CI], 1.386–4.436, P = 0.002). In conclusion, PDW is easily available in routine blood test. Our findings indicated that PDW is an independent predictor and that it may also be a potential parameter for targeted therapy in melanoma.
- Open Access
- 30 May 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (29) , 48138-48144
Higher platelet distribution width predicts poor prognosis in laryngeal cancer
Higher platelet distribution width predicts poor prognosis in laryngeal cancer Higher platelet distribution width predicts poor prognosis in laryngeal cancer
- 30 May 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (29) , 48138-48144
Open AccessHigher platelet distribution width predicts poor prognosis in laryngeal cancer
Higher platelet distribution width predicts poor prognosis in laryngeal cancer Higher platelet distribution width predicts poor prognosis in laryngeal cancer
- Open Access
- 4 March 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (37) , 62600-62605
Mean platelet volume, platelet distribution width and carcinoembryonic antigen to discriminate gastric cancer from gastric ulcer
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Zhi-yuan Yun1,*, Na Li1,*, Xin Zhang1, Huan Zhang1, Yue Bu2, Yuxiang Sun3, Tiemin Liu1,4, Rui-tao Wang1 and Kai-jiang Yu2 1 Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China 2 Department of Intensive Care Unit, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China 3 Departments of Pediatrics & Molecular and Cellular Biology, Children’s Nutrition Research Center, Huffington Center on Aging, Baylor College of Medicine, Houston, TX, USA 4 Department of Internal Medicine, Division of Hypothalamic Research, UT Southwestern Medical Center, Dallas, TX, USA * These authors have contributed equally to this work Correspondence to: Rui-tao Wang, email: // <![CDATA[ mail("ruitaowang","126",0,"") // ]]> Kai-jiang Yu, email: // <![CDATA[ mail("kaijiang_yu","yeah",2,"") // ]]> Keywords: gastric cancer; mean platelet volume; platelet distribution width; diagnosis Received: October 02, 2016 Accepted: February 21, 2017 Published: March 04, 2017
- 4 March 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (37) , 62600-62605
Open AccessMean platelet volume, platelet distribution width and carcinoembryonic antigen to discriminate gastric cancer from gastric ulcer
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Zhi-yuan Yun1,*, Na Li1,*, Xin Zhang1, Huan Zhang1, Yue Bu2, Yuxiang Sun3, Tiemin Liu1,4, Rui-tao Wang1 and Kai-jiang Yu2 1 Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China 2 Department of Intensive Care Unit, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China 3 Departments of Pediatrics & Molecular and Cellular Biology, Children’s Nutrition Research Center, Huffington Center on Aging, Baylor College of Medicine, Houston, TX, USA 4 Department of Internal Medicine, Division of Hypothalamic Research, UT Southwestern Medical Center, Dallas, TX, USA * These authors have contributed equally to this work Correspondence to: Rui-tao Wang, email: // <![CDATA[ mail("ruitaowang","126",0,"") // ]]> Kai-jiang Yu, email: // <![CDATA[ mail("kaijiang_yu","yeah",2,"") // ]]> Keywords: gastric cancer; mean platelet volume; platelet distribution width; diagnosis Received: October 02, 2016 Accepted: February 21, 2017 Published: March 04, 2017
- Open Access
- 21 February 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (12) , 20213-20219
Platelet distribution width correlates with prognosis of gastric cancer
Platelet distribution width correlates with prognosis of gastric cancer
- 21 February 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (12) , 20213-20219
Open AccessPlatelet distribution width correlates with prognosis of gastric cancer
Platelet distribution width correlates with prognosis of gastric cancer